CoreAge Rx vs Pallas Health
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Readers comparing prepaid, dose-independent compounded-injection plans who can confirm their state eligibility and the complete payment terms.
- semaglutide
- From $79/mo12-month prepay
- tirzepatide
- From $129/mo12-month prepay
Before enrolling
The advertised starting $79/$129 monthly equivalents require a 12-month plan paid in full; no month-to-month price was established
Desk Score
Readers who weight named pharmacies and independently verifiable prescribers above cash-flow flexibility, and who can absorb a $597 or $897 charge every twelve weeks rather than a monthly one.
- semaglutide
- $199/mosee conditions
- tirzepatide
- $299/mosee conditions
Before enrolling
There is no month-to-month rung for either compounded molecule — the funnel renders no cadence selector — so the advertised “$199/mo average” is a single $597 charge every twelve weeks divided by three
Our review of CoreAge Rx gives it 94/100 (A), while our review of Pallas Health gives it 87/100 (B+). The score breakdown shows where each provider does better.
Desk Score, dimension by dimension
Same six measured dimensions for both. The green bar marks the stronger score. See the methodology.
94/100
A
87/100
B+
The spec sheet
Check the billing terms before comparing the figures. Our guide to paying for GLP-1 care without insurance explains how medication charges, membership fees and prepaid terms affect what you owe.
| Field | CoreAge Rx | Pallas Health |
|---|---|---|
| Semaglutide | From $79/mo12-month prepayFull plan termsFrom $79/mo (12-month plan paid in full; confirm the complete charge before paying; no month-to-month price established; same price at every dose according to the FAQ; compounded injectable) | $199/mosee conditionsFull plan terms$199/mo average (compounded injectable; $597 billed every 12 weeks after $139 for the first 4 weeks; no month-to-month tier is sold) |
| Tirzepatide | From $129/mo12-month prepayFull plan termsFrom $129/mo (12-month plan paid in full; confirm the complete charge before paying; no month-to-month price established; same price at every dose according to the FAQ; compounded injectable) | $299/mosee conditionsFull plan terms$299/mo average (compounded injectable; $897 billed every 12 weeks after $179 for the first 4 weeks; no month-to-month tier is sold) |
| Coverage | U.S. service; treatment-specific state eligibility confirmed during intake | All 50 states + DC (async in 43; 7 states plus DC require one video visit) |
| Brand-name | Not confirmed here | Brand-name option listed |
| Oral option | Not confirmed here | Not confirmed here |
| Best for | Readers comparing prepaid, dose-independent compounded-injection plans who can confirm their state eligibility and the complete payment terms. | Readers who weight named pharmacies and independently verifiable prescribers above cash-flow flexibility, and who can absorb a $597 or $897 charge every twelve weeks rather than a monthly one. |
| Desk Score | 94/100A | 87/100B+ |
The verdict
Desk pick — CoreAge RxCoreAge Rx has the higher Desk Score, but Pallas Health may be a better fit if it covers your state, offers the prescribed product or has billing terms that work better for you.
Readers comparing prepaid, dose-independent compounded-injection plans who can confirm their state eligibility and the complete payment terms.
Readers who weight named pharmacies and independently verifiable prescribers above cash-flow flexibility, and who can absorb a $597 or $897 charge every twelve weeks rather than a monthly one.
More head-to-heads
- CoreAge Rx vs Strut Health
- Pallas Health vs Sesame Care
- CoreAge Rx vs Ondra Health
- Eden vs Pallas Health
- CoreAge Rx vs Sesame Care
- Pallas Health vs Vytora Health
Or see the full comparison hub and the complete ranking.